These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 11732920)

  • 21. Apolipoprotein E associates with beta amyloid peptide of Alzheimer's disease to form novel monofibrils. Isoform apoE4 associates more efficiently than apoE3.
    Sanan DA; Weisgraber KH; Russell SJ; Mahley RW; Huang D; Saunders A; Schmechel D; Wisniewski T; Frangione B; Roses AD
    J Clin Invest; 1994 Aug; 94(2):860-9. PubMed ID: 8040342
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Apolipoprotein E structural requirements for the formation of SDS-stable complexes with beta-amyloid-(1-40): the role of salt bridges.
    Bentley NM; Ladu MJ; Rajan C; Getz GS; Reardon CA
    Biochem J; 2002 Aug; 366(Pt 1):273-9. PubMed ID: 12015813
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ApoE-fragment/Aβ heteromers in the brain of patients with Alzheimer's disease.
    Mouchard A; Boutonnet MC; Mazzocco C; Biendon N; Macrez N;
    Sci Rep; 2019 Mar; 9(1):3989. PubMed ID: 30850702
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ApoE isoform-specific effects on LTP: blockade by oligomeric amyloid-beta1-42.
    Trommer BL; Shah C; Yun SH; Gamkrelidze G; Pasternak ES; Stine WB; Manelli A; Sullivan P; Pasternak JF; LaDu MJ
    Neurobiol Dis; 2005 Feb; 18(1):75-82. PubMed ID: 15649697
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The ability of apolipoprotein E fragments to promote intraneuronal accumulation of amyloid beta peptide 42 is both isoform and size-specific.
    Dafnis I; Argyri L; Sagnou M; Tzinia A; Tsilibary EC; Stratikos E; Chroni A
    Sci Rep; 2016 Aug; 6():30654. PubMed ID: 27476701
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phosphorylation at Ser
    Hu ZW; Ma MR; Chen YX; Zhao YF; Qiang W; Li YM
    J Biol Chem; 2017 Feb; 292(7):2611-2623. PubMed ID: 28031462
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human apolipoprotein E4 accelerates beta-amyloid deposition in APPsw transgenic mouse brain.
    Carter DB; Dunn E; McKinley DD; Stratman NC; Boyle TP; Kuiper SL; Oostveen JA; Weaver RJ; Boller JA; Gurney ME
    Ann Neurol; 2001 Oct; 50(4):468-75. PubMed ID: 11601499
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Apolipoprotein E isoforms in Alzheimer's disease pathology and etiology.
    Baum L; Chen L; Ng HK; Pang CP
    Microsc Res Tech; 2000 Aug; 50(4):278-81. PubMed ID: 10936880
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Apolipoprotein (apo) E4 enhances amyloid beta peptide production in cultured neuronal cells: apoE structure as a potential therapeutic target.
    Ye S; Huang Y; Müllendorff K; Dong L; Giedt G; Meng EC; Cohen FE; Kuntz ID; Weisgraber KH; Mahley RW
    Proc Natl Acad Sci U S A; 2005 Dec; 102(51):18700-5. PubMed ID: 16344478
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular basis for increased risk for late-onset Alzheimer disease due to the naturally occurring L28P mutation in apolipoprotein E4.
    Argyri L; Dafnis I; Theodossiou TA; Gantz D; Stratikos E; Chroni A
    J Biol Chem; 2014 May; 289(18):12931-45. PubMed ID: 24644280
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A dual role for apolipoprotein e in neuroinflammation: anti- and pro-inflammatory activity.
    Guo L; LaDu MJ; Van Eldik LJ
    J Mol Neurosci; 2004; 23(3):205-12. PubMed ID: 15181248
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The pathogenic implication of abnormal interaction between apolipoprotein E isoforms, amyloid-beta peptides, and sulfatides in Alzheimer's disease.
    Han X
    Mol Neurobiol; 2010 Jun; 41(2-3):97-106. PubMed ID: 20052565
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human ApoE Isoforms Differentially Modulate Glucose and Amyloid Metabolic Pathways in Female Brain: Evidence of the Mechanism of Neuroprotection by ApoE2 and Implications for Alzheimer's Disease Prevention and Early Intervention.
    Keeney JT; Ibrahimi S; Zhao L
    J Alzheimers Dis; 2015; 48(2):411-24. PubMed ID: 26402005
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blocking the apolipoprotein E/amyloid-beta interaction as a potential therapeutic approach for Alzheimer's disease.
    Sadowski MJ; Pankiewicz J; Scholtzova H; Mehta PD; Prelli F; Quartermain D; Wisniewski T
    Proc Natl Acad Sci U S A; 2006 Dec; 103(49):18787-92. PubMed ID: 17116874
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Apolipoprotein E dose-dependent modulation of beta-amyloid deposition in a transgenic mouse model of Alzheimer's disease.
    DeMattos RB
    J Mol Neurosci; 2004; 23(3):255-62. PubMed ID: 15181254
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitation of apoE domains in Alzheimer disease brain suggests a role for apoE in Abeta aggregation.
    Cho HS; Hyman BT; Greenberg SM; Rebeck GW
    J Neuropathol Exp Neurol; 2001 Apr; 60(4):342-9. PubMed ID: 11305869
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quercetin stabilizes apolipoprotein E and reduces brain Aβ levels in amyloid model mice.
    Zhang X; Hu J; Zhong L; Wang N; Yang L; Liu CC; Li H; Wang X; Zhou Y; Zhang Y; Xu H; Bu G; Zhuang J
    Neuropharmacology; 2016 Sep; 108():179-92. PubMed ID: 27114256
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A nontransgenic mouse model shows inducible amyloid-beta (Abeta) peptide deposition and elucidates the role of apolipoprotein E in the amyloid cascade.
    Dolev I; Michaelson DM
    Proc Natl Acad Sci U S A; 2004 Sep; 101(38):13909-14. PubMed ID: 15365176
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-affinity multivalent interactions between apolipoprotein E and the oligomers of amyloid-β.
    Ghosh S; Sil TB; Dolai S; Garai K
    FEBS J; 2019 Dec; 286(23):4737-4753. PubMed ID: 31287614
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ApoE-isoform-dependent cellular uptake of amyloid-β is mediated by lipoprotein receptor LR11/SorLA.
    Yajima R; Tokutake T; Koyama A; Kasuga K; Tezuka T; Nishizawa M; Ikeuchi T
    Biochem Biophys Res Commun; 2015 Jan; 456(1):482-8. PubMed ID: 25482438
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.